This announcement is a separate document:
国邦医药2023年年度股东大会决议公告
Announcement of Resolutions of Guobang Pharmaceutical's 2023 Annual General Meeting of Shareholders
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Latest
02:16
On Friday, December 6th, the overnight reverse repurchase agreement (RRP) usage amount was 130.014 billion US dollars, down from 131.964 billion US dollars on the previous trading day.
02:16
Blackrock: It is expected that retail investors will rush to buy municipal bonds in 2025.
BLK-0.13%
02:13
The Deputy Minister of Economy of Mexico: Mexican officials have been in contact with allies of Trump, but not with the incoming government officials.
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.